Bradyzide is a potent, non-peptide B₂ bradykinin receptor antagonist mainly used in pharmacological and biomedical research. It blocks the action of bradykinin, a peptide in the body that triggers inflammation, blood vessel widening, and pain signals. It is grouped under the following drug class(es): Bradykinin B2 receptor antagonists. Other names for this substance include (2S)-N-(2-(2-dimethylaminoethyl-methylamino)ethyl)-1-(4-(2-(di(phenyl)methylcarbamothioyl)hydrazinyl)-3-nitrophenyl)sulfonylpyrrolidine-2-carboxamide and 1-(4-(4-benzhydrylthiosemicarbazido)-3-nitrobenzenesulfonyl)pyrrolidine-2-carboxylic acid. Its PubChem CID is 5312119.
Bradyzide
| Molecular Formula | C32H42N8O5S2 |
|---|---|
| Molecular Weight | 682.9 g/mol |
| Synonyms | (2S)-1-[4-[2-(benzhydrylcarbamothioyl)hydrazinyl]-3-nitrophenyl]sulfonyl-N-[2-[2-(dimethylamino)ethyl-methylamino]ethyl]pyrrolidine-2-carboxamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Bradyzide is a potent, non-peptide B₂ bradykinin receptor antagonist mainly used in pharmacological and biomedical research. It blocks the action of bradykinin, a peptide in the body that triggers inflammation, blood vessel widening, and pain signals.
The listed molecular formula is C32H42N8O5S2.
The listed molecular weight is 682.9 g/mol.
(2S)-1-[4-[2-(benzhydrylcarbamothioyl)hydrazinyl]-3-nitrophenyl]sulfonyl-N-[2-[2-(dimethylamino)ethyl-methylamino]ethyl]pyrrolidine-2-carboxamide.
The source lists (2S)-N-(2-(2-dimethylaminoethyl-methylamino)ethyl)-1-(4-(2-(di(phenyl)methylcarbamothioyl)hydrazinyl)-3-nitrophenyl)sulfonylpyrrolidine-2-carboxamide and 1-(4-(4-benzhydrylthiosemicarbazido)-3-nitrobenzenesulfonyl)pyrrolidine-2-carboxylic acid.
It is listed under Bradykinin B2 receptor antagonists.